Overseas Investment News- China Business Network

Home > Overseas Investment News

Overseas Investment News

2021-07-05Suning's rural retailer Retail Cloud will open 900 new stores in Q3
2021-07-02TD Holdings, Inc. Regains Compliance with Nasdaq's Listing Requirements
2021-07-02Telling Hainan's history for 100 years with 22 meters of heritage
2021-07-01New-Generation Intelligent Pickup Truck, GWM POER Wins Praise from Media
2021-07-01Dogness Adds Three New Distributors to Meet Growth
2021-07-01Daqo New Energy Issues Its First Environmental, Social and Governance (ESG) Report
2021-06-30Senmiao Technology to Report Fiscal 2021 Year-end Financial Results by July 9, 2021
2021-06-30Puhui Wealth Investment Management Co. Ltd. Announces Financial Results for the Six Months Ended December 31, 2020
2021-06-29MingZhu Logistics Announces Audited Full Year 2020 Financial Results
2021-06-29Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
2021-06-28Innovent Announces the China NMPA Approval of TYVYT? (sintilimab injection) in Combination with BYVASDA? (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
2021-06-28Far More Than Walmart China -- How VeChain Leads Blockchain Adoption in the Food Industry Around the Globe
2021-06-25Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE
2021-06-25Fuwei Films Announces Its Unaudited Financial Results for the First Quarter of 2021
2021-06-24CStone announces positive GAVRETO? (pralsetinib) registrational study data for first-line treatment of advanced RET fusion-positive non-small cell lung cancer and plans to submit a new indication application
2021-06-24The investor who incorporates altruism into the business model
2021-06-23Cloud-based enterprise software provider Eka to transform corporate treasury operations with a new, purpose-built, state-of-the-art solution
2021-06-23A Hit in China, GWM's TANK About to Debut the Global Market
2021-06-22Innovent Announces the Approval of Pemazyre? (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
2021-06-22The People Who Build Xinjiang

First　Previous　76 77 78 79 80　Next　Last　Total 3982 20/Page Page 78 of 200 Go To: